Aetna Inc (AET) Stake Lessened by Goelzer Investment Management Inc.

Goelzer Investment Management Inc. reduced its position in shares of Aetna Inc (NYSE:AET) by 3.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 21,245 shares of the company’s stock after selling 740 shares during the period. Goelzer Investment Management Inc.’s holdings in Aetna were worth $3,832,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in AET. GSA Capital Partners LLP purchased a new stake in shares of Aetna during the 2nd quarter worth $350,000. BlueCrest Capital Management Ltd purchased a new stake in shares of Aetna during the 2nd quarter worth $425,000. Laurel Wealth Advisors Inc. purchased a new stake in shares of Aetna during the 2nd quarter worth $202,000. Raymond James Financial Services Advisors Inc. lifted its position in shares of Aetna by 6.2% during the 2nd quarter. Raymond James Financial Services Advisors Inc. now owns 39,593 shares of the company’s stock worth $6,011,000 after purchasing an additional 2,307 shares during the last quarter. Finally, BB&T Investment Services Inc. purchased a new stake in shares of Aetna during the 2nd quarter worth $245,000. 87.41% of the stock is owned by institutional investors and hedge funds.

Shares of Aetna Inc (NYSE AET) opened at $178.00 on Friday. Aetna Inc has a 1 year low of $120.39 and a 1 year high of $194.40. The firm has a market cap of $59,310.93, a price-to-earnings ratio of 30.96, a P/E/G ratio of 1.47 and a beta of 0.60. The company has a quick ratio of 0.53, a current ratio of 1.68 and a debt-to-equity ratio of 0.52.

Aetna (NYSE:AET) last posted its quarterly earnings data on Tuesday, January 30th. The company reported $1.25 EPS for the quarter, beating analysts’ consensus estimates of $1.18 by $0.07. The company had revenue of $14.74 billion for the quarter, compared to analyst estimates of $14.79 billion. Aetna had a net margin of 3.15% and a return on equity of 21.50%. Aetna’s quarterly revenue was down 6.2% on a year-over-year basis. During the same period in the previous year, the business posted $0.08 earnings per share. equities analysts predict that Aetna Inc will post 10.99 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 26th. Shareholders of record on Thursday, January 11th were paid a $0.50 dividend. The ex-dividend date was Wednesday, January 10th. This represents a $2.00 dividend on an annualized basis and a yield of 1.12%. Aetna’s dividend payout ratio is presently 34.78%.

Several equities research analysts have recently issued reports on AET shares. Zacks Investment Research raised shares of Aetna from a “hold” rating to a “buy” rating and set a $174.00 price objective for the company in a research report on Thursday, October 12th. ValuEngine raised shares of Aetna from a “hold” rating to a “buy” rating in a research report on Sunday, December 31st. Piper Jaffray Companies raised shares of Aetna from a “neutral” rating to an “overweight” rating and set a $136.00 price target for the company in a research report on Wednesday, January 3rd. Argus cut shares of Aetna from a “buy” rating to a “hold” rating and set a $185.00 price target for the company. in a research report on Wednesday, December 6th. Finally, Morgan Stanley cut shares of Aetna from an “overweight” rating to an “equal weight” rating and set a $179.00 price target for the company. in a research report on Wednesday, December 20th. Ten analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. Aetna presently has a consensus rating of “Buy” and an average price target of $185.94.

TRADEMARK VIOLATION WARNING: This piece was reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this piece on another domain, it was stolen and reposted in violation of US and international copyright and trademark law. The original version of this piece can be accessed at https://sportsperspectives.com/2018/02/09/aetna-inc-aet-stake-lessened-by-goelzer-investment-management-inc.html.

Aetna Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply